No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cardiopulmonary Resuscitation
-
Chest Pain / etiology
-
Combined Modality Therapy
-
Cytarabine / administration & dosage
-
Defibrillators, Implantable
-
Echocardiography
-
Etoposide / administration & dosage
-
Heart Arrest / etiology*
-
Heart Arrest / therapy
-
Humans
-
Idarubicin / administration & dosage
-
Idarubicin / adverse effects*
-
Leukemia, Myeloid, Acute / complications
-
Leukemia, Myeloid, Acute / drug therapy
-
Magnetic Resonance Imaging
-
Male
-
Middle Aged
-
Myocarditis / chemically induced*
-
Myocarditis / complications
-
Myocarditis / diagnostic imaging
-
Ventricular Fibrillation / chemically induced*
-
Ventricular Fibrillation / complications
-
Ventricular Fibrillation / therapy
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Cytarabine
-
Etoposide
-
Idarubicin